HAI-2 Antibodies

Santa Cruz Biotechnology features a diverse variety of HAI-2 monoclonal antibodies for research in understanding HAI-2's role in various biological processes. HAI-2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HAI-2, or hepatocyte growth factor activator inhibitor type 2, is a crucial protein involved in regulating serine proteases, which play significant roles in cell signaling, tissue remodeling, and inflammation. Through protease inhibition, HAI-2 maintains cellular homeostasis and influences cancer progression and metastasis. Research has shown that HAI-2 expression levels vary across different tissue types and developmental stages. Understanding HAI-2's molecular mechanisms and regulatory pathways can provide valuable insights into disease development and potential therapeutic strategies. HAI-2's role in cancer biology has emerged as a particularly important area of study, with implications for both diagnostic and therapeutic applications. Investigating HAI-2's interactions with other proteins helps reveal its broader influence on cellular processes and disease pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of HAI-2's role in health and disease.